Skip to main content
SpringerLink
Log in

Evolving therapeutic strategies for acromegaly

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rajasoorya C., Holdaway I.M., Wrightson P., Scott D.J., Ibbertson H.K. Determinants of clinical outcome and survival in acromegaly. Clin. Endocrinol. 1994, 41: 95–102.

    Article  CAS  Google Scholar 

  2. Bates A.S., Van’t Hoff W., Jones J.M., Clayton R.N. An audit of outcome of treatment in acromegaly. Q. J. Med. 1993, 86: 293–299.

    CAS  PubMed  Google Scholar 

  3. Swearingen B., Barker II F.G., Katznelson L., Biller B.M.K., Grinspoon S., Klibanski A., Moayeri N., Black P.M.C.L., Zervas N.T. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J. Clin. Endocrinol. Metab. 1998, 83: 3419–3426.

    CAS  PubMed  Google Scholar 

  4. Ahmed S., Elsheikh M., Stratton I.M., Page R.C.L., Adams C.B.T., Wass J.A.H. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin. Endocrinol. 1999, 50: 561–567.

    Article  CAS  Google Scholar 

  5. Gittoes N.J., Sheppard M.C., Johnson A.P., Stewart P.M. Outcome of surgery for acromegaly — the experience of a dedicated pituitary surgeon. Q.J.M. 1999, 92: 741–745.

    Article  CAS  Google Scholar 

  6. Lissett C.A., Peacey S.R., Laing I., Tetlow L., Davis J.R.E., Shalet S.M. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clin. Endocrinol. 1998, 49: 653–657.

    Article  CAS  Google Scholar 

  7. Yamada S., Takada K., Ozawa Y., Shimizu T., Sawano S., Shishiba Y., Sano T., Usui M. The results of transsphenoidal surgery for 44 consecutive acromegalic patients. Endocr. J. 1997, 44: 395–402.

    Article  CAS  PubMed  Google Scholar 

  8. Eastman R.C., Gorden P., Glatstein E., Roth J. Radiation therapy of acromegaly. Endocrinol. Metab. Clin. North Am. 1992, 21: 693–712.

    CAS  PubMed  Google Scholar 

  9. Littley M.D., Shalet S.M., Swindell R., Beardwell C.G., Sutton M.L. Low-dose pituitary irradiation for acromegaly. Clin. Endocrinol. 1990, 32: 261–270.

    Article  CAS  Google Scholar 

  10. Barkan A.P., Halasz I., Dornfeld K.J., Jaffe C.A., Friberg R.D., Chandler W.F., Sandler S.M. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J. Clin. Endocrinol. Metab. 1997, 82: 3187–3191.

    CAS  PubMed  Google Scholar 

  11. Biermasz N.R., Dulken H., Roelfsema F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J. Clin. Endocrinol. Metab. 2000, 85: 2476–2482.

    Article  CAS  PubMed  Google Scholar 

  12. Ramos M., Regis I.J., Dufour H., Andrieu J.M., Grisoli F., Jaquet P., Peragut J.C. Gamma-knife surgery for secreting pituitary adenomas. Acta. Neurochir. Wien 1998, 140: 437–443.

    Article  Google Scholar 

  13. Landolt A.M., Haller D., Lomax N., Scheib S., Schubiger O., Siegfried J., Wellis G. Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J. Neurosurg. 1998, 88: 1002–1008.

    Article  CAS  PubMed  Google Scholar 

  14. Abs R., Verhelst J., Matter D., Van Acker K., Beckers A. Cabergoline in the treatment of acromegaly: a study in 64 patients. J. Clin. Endocrinol. Metab. 1998, 83: 374–378.

    Article  CAS  PubMed  Google Scholar 

  15. Newman C.B., Melmed S., Snyder P.J., Young W.F., Boyajy L.D., Levy R., Stewart W.N., Klibanski A., Molitch M.E., Gagel R.F., Boyd A.E., Sheeler L., Cook D., Malarkey W.B., Jackson I.M.D., Lee Vance M., Thorner M.O., Ho P.J., Jaffe C.A., Frohman L.A., Kleinberg D.L. Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients-a clinical research center study. [published erratum appears in J. Clin. Endocrinol. Metab. 1995, 80: 3238]. J. Clin. Endocrinol. Metab. 1995, 80: 2768–2775.

    CAS  Google Scholar 

  16. Newman C.B. Medical therapy for acromegaly. Endocrinol. Metab. Clin. North Am. 1999, 28: 171–190.

    Article  CAS  PubMed  Google Scholar 

  17. Lancranjan L., Atkinson A.B., the Sandostatin LAR Group. Results of a European multicentre study with sandostatin LAR in acromegalic patients. Pituitary 1999, 1: 105–114.

    Article  CAS  PubMed  Google Scholar 

  18. Davies P.H., Stewart S.E., Lancranjan L., Shepard M.C., Stewart P.M. Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly. [published erratum appears in Clin. Endocrinol. (Oxf.) 1998, 48: 673]. Clin. Endocrinol. 1998, 48: 311–316.

    Google Scholar 

  19. Turner H.E., Vadivale A., Keenan J., Wass J.A.H. A comparison of lanreotide and octreotide LAR for treatment of acromegaly. Clin. Endocrinol. 1999, 51: 275–80.

    Article  CAS  Google Scholar 

  20. Trainer P.J., Drake W.M., Kaiznelson L., Freda P.U., Herman-Bonert V., Van Der Lely A.J., Dimaraki E.V., Stewart P.M., Friend K.E., Lee Vance M., Bessar G.M., Scarlett J.A. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N. Engl. J. Med. 2000, 342: 1171–1177.

    Article  CAS  PubMed  Google Scholar 

  21. Newman C.B., Melmed S., George A., Torigian D., Duhaney M., Snyder P., Young W., Klibanski A., Molitch M.E., Gagel R., Sheeler L., Cook D., Malarkey W., Jackson I., Lee Vance M., Barkan A., Frohman L., Kleinberg D.L. Octreotide as primary therapy for acromegaly. J. Clin. Endocrinol. Metab. 1998, 83: 3034–3040.

    CAS  PubMed  Google Scholar 

  22. Kristof R.A., Stoffel-Wagner B., Klingmuller D., Schramm J. Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly? A randomized study. Acta Neurochir. Wien 1999, 141: 399–405.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Christie Hospital, Wilmslow Road, Withington, Manchester, M20 4BX, UK

    K. H. Darzy &  S. M. Shalet

Authors
  1. K. H. Darzy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. M. Shalet
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Darzy, K.H., Shalet, S.M. Evolving therapeutic strategies for acromegaly. J Endocrinol Invest 24, 468–471 (2001). https://doi.org/10.1007/BF03351049

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03351049

Keywords

Search

Navigation